Literature DB >> 33397928

Homeostatic regulation of STING by retrograde membrane traffic to the ER.

Kojiro Mukai1, Emari Ogawa2, Rei Uematsu2, Yoshihiko Kuchitsu1, Fumika Kiku2, Takefumi Uemura3, Satoshi Waguri3, Takehiro Suzuki4, Naoshi Dohmae4, Hiroyuki Arai2, Anthony K Shum5, Tomohiko Taguchi6.   

Abstract

Coat protein complex I (COP-I) mediates the retrograde transport from the Golgi apparatus to the endoplasmic reticulum (ER). Mutation of the COPA gene, encoding one of the COP-I subunits (α-COP), causes an immune dysregulatory disease known as COPA syndrome. The molecular mechanism by which the impaired retrograde transport results in autoinflammation remains poorly understood. Here we report that STING, an innate immunity protein, is a cargo of the retrograde membrane transport. In the presence of the disease-causative α-COP variants, STING cannot be retrieved back to the ER from the Golgi. The forced Golgi residency of STING results in the cGAS-independent and palmitoylation-dependent activation of the STING downstream signaling pathway. Surf4, a protein that circulates between the ER/ ER-Golgi intermediate compartment/ Golgi, binds STING and α-COP, and mediates the retrograde transport of STING to the ER. The STING/Surf4/α-COP complex is disrupted in the presence of the disease-causative α-COP variant. We also find that the STING ligand cGAMP impairs the formation of the STING/Surf4/α-COP complex. Our results suggest a homeostatic regulation of STING at the resting state by retrograde membrane traffic and provide insights into the pathogenesis of COPA syndrome.

Entities:  

Year:  2021        PMID: 33397928     DOI: 10.1038/s41467-020-20234-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  17 in total

1.  The STING phase-separator suppresses innate immune signalling.

Authors:  Xiaoyu Yu; Liyuan Zhang; Jingxiang Shen; Yanfang Zhai; Qifei Jiang; Mengran Yi; Xiaobing Deng; Ziran Ruan; Run Fang; Zhaolong Chen; Xiaohan Ning; Zhengfan Jiang
Journal:  Nat Cell Biol       Date:  2021-04-08       Impact factor: 28.824

Review 2.  No Longer A One-Trick Pony: STING Signaling Activity Beyond Interferon.

Authors:  Jianjun Wu; Nan Yan
Journal:  J Mol Biol       Date:  2021-10-08       Impact factor: 5.469

3.  Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation.

Authors:  Masahiko Nishitani-Isa; Kojiro Mukai; Yoshitaka Honda; Hiroshi Nihira; Takayuki Tanaka; Hirofumi Shibata; Kumi Kodama; Eitaro Hiejima; Kazushi Izawa; Yuri Kawasaki; Mitsujiro Osawa; Yu Katata; Sachiko Onodera; Tatsuya Watanabe; Takashi Uchida; Shigeo Kure; Junko Takita; Osamu Ohara; Megumu K Saito; Ryuta Nishikomori; Tomohiko Taguchi; Yoji Sasahara; Takahiro Yasumi
Journal:  J Exp Med       Date:  2022-04-28       Impact factor: 17.579

Review 4.  Organellar homeostasis and innate immune sensing.

Authors:  Cassandra R Harapas; Elina Idiiatullina; Mahmoud Al-Azab; Katja Hrovat-Schaale; Thomas Reygaerts; Annemarie Steiner; Pawat Laohamonthonkul; Sophia Davidson; Chien-Hsiung Yu; Lee Booty; Seth L Masters
Journal:  Nat Rev Immunol       Date:  2022-02-23       Impact factor: 108.555

Review 5.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

6.  A Novel Mutation c.841C>T in COPA Syndrome of an 11-Year-Old Boy: A Case Report and Short Literature Review.

Authors:  Jingxia Zeng; Jing Hao; Wei Zhou; Zhaoqun Zhou; Hongjun Miao
Journal:  Front Pediatr       Date:  2021-11-24       Impact factor: 3.418

Review 7.  The type I interferonopathies: 10 years on.

Authors:  Yanick J Crow; Daniel B Stetson
Journal:  Nat Rev Immunol       Date:  2021-10-20       Impact factor: 108.555

Review 8.  STING1 in Different Organelles: Location Dictates Function.

Authors:  Ruoxi Zhang; Rui Kang; Daolin Tang
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

9.  Surf4 facilitates reprogramming by activating the cellular response to endoplasmic reticulum stress.

Authors:  Li Wu; Shengxiang He; Wen Ye; Jiacheng Shen; Kun Zhao; Yanping Zhang; Ran Zhang; Junhao Wei; Shuyuan Cao; Kang Chen; Rongrong Le; Chenxiang Xi; Xiaochen Kou; Yanhong Zhao; Hong Wang; Lan Kang; Shaorong Gao
Journal:  Cell Prolif       Date:  2021-09-28       Impact factor: 6.831

Review 10.  Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity.

Authors:  Jérôme Hadjadj; Marie-Louise Frémond; Bénédicte Neven
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.